Home » Newsletters » BioWorld Science

BioWorld Science

June 18, 2001

View Archived Issues

Shire to evaluate CX-516 in phase II for ADHD

Climodien continuous combined HRT cleared in E.U.

COX-2 inhibitor SVT-2016 characterized by good safety and suitable pharmacokinetics in man

Dainippon compound more potent than leflunomide in animal models of arthritis/autoimmune diseases

LDP-341 enters clinical trials in combination with gemcitabine and irinotecan

EULAR 2001: SMP-114 protects against both inflammation and joint destruction in arthritis

Genzyme substrate inhibitor compound shows advantages over first-generation inhibitors

FDA approves extended indication for delayed-release Protonix

Nymox discovers new family of compounds

Relpax approved in E.U. for migraine

Mucoregulators identified at Genaera with potential in COPD

Patient enrollment complete in safety trial with Miravant topical PhotoPoint drug

Selective presynaptic M2 antagonist facilitates acetylcholine release, improves cognition

Boehringer Ingelheim announces TRANSCEND trial in ACE-intolerant patients

Potent inhibitors of cGMP-PDE and potential uses reported in international patent

Takeda presents new compounds inhibiting steroid C17,20 lyase

Recent patent covers new NF-kB modulators from Aventis

Diaryl-enynes from NPS Allelix particularly useful for Alzheimer's disease

BMS synthesizes wide series of PTK inhibitors

Novel antibacterial agents designed by Abbott research team

Company Profile: GTx

BD Biosciences and Dyax to collaborate on antibody discovery

A novel ICP34.5-deleted HSV-1 virus for cancer therapy

Coagulin-B in second human hemophilia gene therapy trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...